ctrl K

Watchlist Price Alert

Theseus Pharmaceuticals I... (THRX)

NASDAQ: THRX · Real-Time Price · USD

4.07

0.01 (0.25%)

At close: Feb 13, 2024, 8:59 PM

Theseus Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	438K	2K	2K	2K
Gross Profit	-438K	-2K	-2K	-2K
Operating Income	-54.09M	-27.34M	-6.84M	-4.94M
Interest Income	n/a	28.00	n/a	n/a
Pretax Income	-50.61M	-27.31M	-12M	-7.18M
Net Income	-47.08M	-27.31M	-12M	-7.18M
Selling & General & Admin	18.39M	9.01M	878K	818K
Research & Development	35.7M	18.33M	5.96M	4.12M
Other Expenses	3.48M	28K	-5.16M	-2.24M
Operating Expenses	54.09M	27.34M	6.84M	4.94M
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	54.09M	27.34M	6.84M	4.94M
Income Tax Expense	-3.53M	n/a	n/a	n/a
Shares Outstanding (Basic)	38.49M	9.63M	25.37M	11.92M
Shares Outstanding (Diluted)	38.49M	9.63M	25.37M	11.92M
EPS (Basic)	-1.22	-2.84	-0.47	-0.6
EPS (Diluted)	-1.22	-2.84	-0.47	-0.6
EBITDA	-54.09M	-27.33M	-6.83M	-4.94M
EBIT	-54.14M	n/a	n/a	n/a
Depreciation & Amortization	50K	2K	2K	2K